IDEXX Laboratories, Inc. Profile Avatar - Palmy Investing

IDEXX Laboratories, Inc.

IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Produ…
Medical - Diagnostics & Research
US, Westbrook [HQ]

Ratios

15 Sheets · Starting from 2023
Margins, Growth Rates In %
Ratio 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Profitability
Gross Margin
51.01 52.44 53.05 54.06 54.91 54.93 55.58 54.94 55.73 56.10 56.73 58.04 58.76 59.52 59.82
Profit Margin
11.85 12.80 13.28 13.78 13.64 12.24 11.99 12.51 13.36 17.04 17.77 21.49 23.17 20.17 23.08
Operating Margin
17.06 18.48 19.38 20.30 19.37 17.52 18.72 19.73 20.98 22.20 22.97 25.66 28.99 26.69 29.97
EPS Growth
7.22 18.27 16.26 13.29 9.26 2.83 13.74 19.32 21.46 44.67 14.52 37.22 28.15 -7.09 25.25
Return on Assets (ROA)
15.12 15.75 15.69 16.15 15.26 13.14 13.02 14.51 15.36 24.52 23.34 25.35 30.56 24.72 25.92
Return on Equity (ROE)
23.75 24.60 29.98 28.02 36.24 154.79 -228.32 -204.93 -486.35 -3,963.32 241.01 92.04 107.95 111.56 56.92
Return on Invested Capital (ROIC)
19.30 20.15 20.74 21.11 20.10 18.89 19.43 22.05 23.64 40.85 38.87 39.64 47.66 36.26 35.92
Solvency
Equity Ratio
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Debt/Assets
15.32 14.86 23.91 19.44 34.81 64.95 79.33 78.66 73.60 65.07 53.90 39.59 37.90 49.09 29.08
Debt/Equity
24.08 23.21 45.67 33.72 82.67 765.00 -1,390.89 -1,111.30 -2,330.75 -10,514.93 556.52 143.73 133.87 221.50 63.85
Debt/EBITDA
9.75 -11.59 26.47 -3.61 55.98 221.50 337.88 299.57 259.89 178.39 162.31 75.53 83.61 137.50 45.02
Debt/Capitalization
19.40 18.84 31.35 25.21 45.26 88.44 107.75 109.89 104.48 100.96 84.77 58.97 57.24 68.90 38.97
Interest Debt per Share USD
1.07 1.17 2.19 1.97 4.06 9.12 12.92 13.74 14.73 11.90 11.82 11.03 11.19 16.59 10.98
Debt Growth
-20.83 7.59 84.89 -12.95 99.72 109.85 30.15 2.91 4.73 -20.68 -1.26 -8.02 1.68 45.98 -29.70
Liquidity
Current Ratio
146.83 161.55 119.99 140.17 136.45 92.51 95.90 90.48 96.76 84.91 93.70 182.36 125.15 89.13 157.14
Quick Ratio
86.55 97.15 74.43 89.17 91.38 57.85 61.97 63.81 70.33 48.37 49.58 122.75 67.16 41.52 95.78
Cash Ratio
41.64 55.04 42.09 55.12 58.34 39.29 15.06 16.57 18.68 16.07 12.45 65.88 18.92 9.11 47.70
Operating Cash Flow Ratio
- - - - - - - - - - - - - - - - - - - - - - 100 - - - - - -
Turnover
Inventory Turnover
457.64 410.34 429.89 421.57 465.38 417.66 376.85 506.21 530.48 560.69 533.98 541.10 492.86 370.56 386.81
Receivables Turnover
896.24 918.88 862.64 935.01 871.35 975.07 850.63 868.20 839.34 889.37 893.73 816.66 872.91 840.53 800.31
Payables Turnover
2,641.26 2,314.92 1,565.44 1,683.83 2,073.88 1,496.75 1,351.66 1,332.05 1,301.63 1,397.45 1,442.89 1,523.13 1,141.66 1,236.59 1,329.49
Asset Turnover
127.59 122.99 118.23 117.19 111.91 107.34 108.60 115.99 114.92 143.96 131.35 117.96 131.93 122.59 112.30
Coverage
Interest Coverage
12,305.52 11,637.04 13,101.77 13,492.45 7,619.59 1,899.67 1,120.29 1,233.54 1,291.88 1,462.61 1,805.03 2,134.44 3,172.97 2,316.82 -3,051.65
Asset Coverage
400 500 300 300 200 100 - - - - 100 100 100 100 100 100 200
Cash Flow Coverage (CFGR)
140.23 134.18 89.56 107.36 57.42 26.23 18.49 27.79 29.60 40.00 46.49 71.33 81.80 40.27 95.64
EBITDA Coverage
12,300 11,600 13,100 13,400 7,600 1,800 1,100 1,200 1,200 1,400 1,800 2,100 3,100 2,300 -3,000
Dividend Coverage
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Time Interest Earned (TIE)
100 100 100 100 100 100 100 100 100 100 100 100 100 100 200
Market Prospects
Dividend Yield
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Earnings Yield
3.89 3.54 3.70 3.49 3.32 2.45 2.85 2.11 1.92 2.33 1.90 1.36 1.33 1.99 1.83
Price/Earnings (P/E)
2,571.77 2,827.56 2,701.44 2,862.34 3,010.93 4,079.29 3,515.48 4,739.07 5,215.90 4,285.71 5,257.46 7,332.70 7,531.87 5,023.62 5,456.03
Price/Book (P/B)
610.87 695.69 809.99 802.02 1,091.21 6,314.43 -8,026.70 -9,711.75 -25,367.46 -169,856.42 12,670.78 6,749.05 8,130.64 5,604.20 3,105.75
Price/Sales (P/S)
304.70 362.06 358.63 394.53 410.62 499.42 421.53 592.70 697.05 730.08 934.28 1,576.11 1,744.77 1,013.11 1,259.39
Price/Cash Flow (P/CF)
1,809.45 2,233.87 1,980.32 2,215.81 2,298.62 3,146.32 3,120.88 3,145.18 3,676.99 4,038.76 4,897.49 6,582.68 7,425.20 6,282.84 5,086.08
End of IDXX's Analysis
CIK: 874716 CUSIP: 45168D104 ISIN: US45168D1046 LEI: - UEI: -
Secondary Listings